Publication | Closed Access

A new potential oncogenic mutation in the FERM domain of JAK2 in BCR/ABL1-negative and V617F-negative chronic myeloproliferative neoplasms revealed by a comprehensive screening of 17 tyrosine kinase coding genes

Hematological MalignancyMedicineTyrosine KinaseHematologyPathologyFerm DomainComprehensive ScreeningMolecular DiagnosticsCell BiologyTumor BiologyJak-stat Signaling PathwayMyeloid Neoplasia